IBDEI0G9 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7214,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer,Right Lower Leg Oth Part
 ;;^UTILITY(U,$J,358.3,7214,1,4,0)
 ;;=4^L97.819
 ;;^UTILITY(U,$J,358.3,7214,2)
 ;;=^5009564
 ;;^UTILITY(U,$J,358.3,7215,0)
 ;;=L97.829^^49^479^119
 ;;^UTILITY(U,$J,358.3,7215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7215,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer,Left Lower Leg Oth Part
 ;;^UTILITY(U,$J,358.3,7215,1,4,0)
 ;;=4^L97.829
 ;;^UTILITY(U,$J,358.3,7215,2)
 ;;=^5009569
 ;;^UTILITY(U,$J,358.3,7216,0)
 ;;=L98.419^^49^479^114
 ;;^UTILITY(U,$J,358.3,7216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7216,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer,Buttock
 ;;^UTILITY(U,$J,358.3,7216,1,4,0)
 ;;=4^L98.419
 ;;^UTILITY(U,$J,358.3,7216,2)
 ;;=^5009581
 ;;^UTILITY(U,$J,358.3,7217,0)
 ;;=L98.429^^49^479^113
 ;;^UTILITY(U,$J,358.3,7217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7217,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer,Back
 ;;^UTILITY(U,$J,358.3,7217,1,4,0)
 ;;=4^L98.429
 ;;^UTILITY(U,$J,358.3,7217,2)
 ;;=^5009586
 ;;^UTILITY(U,$J,358.3,7218,0)
 ;;=L98.499^^49^479^127
 ;;^UTILITY(U,$J,358.3,7218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7218,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer,Skin
 ;;^UTILITY(U,$J,358.3,7218,1,4,0)
 ;;=4^L98.499
 ;;^UTILITY(U,$J,358.3,7218,2)
 ;;=^5009591
 ;;^UTILITY(U,$J,358.3,7219,0)
 ;;=M90.80^^49^479^128
 ;;^UTILITY(U,$J,358.3,7219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7219,1,3,0)
 ;;=3^Osteopathy in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,7219,1,4,0)
 ;;=4^M90.80
 ;;^UTILITY(U,$J,358.3,7219,2)
 ;;=^5015168
 ;;^UTILITY(U,$J,358.3,7220,0)
 ;;=Z83.3^^49^479^89
 ;;^UTILITY(U,$J,358.3,7220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7220,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,7220,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,7220,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,7221,0)
 ;;=Z79.4^^49^479^95
 ;;^UTILITY(U,$J,358.3,7221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7221,1,3,0)
 ;;=3^Long Term (Current) Use of Insulin
 ;;^UTILITY(U,$J,358.3,7221,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,7221,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,7222,0)
 ;;=Z09.^^49^479^88
 ;;^UTILITY(U,$J,358.3,7222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7222,1,3,0)
 ;;=3^F/U Exam After Treatment,Not Malig Neop
 ;;^UTILITY(U,$J,358.3,7222,1,4,0)
 ;;=4^Z09.
 ;;^UTILITY(U,$J,358.3,7222,2)
 ;;=^5062668
 ;;^UTILITY(U,$J,358.3,7223,0)
 ;;=Z76.0^^49^479^92
 ;;^UTILITY(U,$J,358.3,7223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7223,1,3,0)
 ;;=3^Issue of Repeat Prescription
 ;;^UTILITY(U,$J,358.3,7223,1,4,0)
 ;;=4^Z76.0
 ;;^UTILITY(U,$J,358.3,7223,2)
 ;;=^5063297
 ;;^UTILITY(U,$J,358.3,7224,0)
 ;;=E10.11^^49^479^36
 ;;^UTILITY(U,$J,358.3,7224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7224,1,3,0)
 ;;=3^Diabetes Type 1 w/ Ketacidosis w/ Coma
 ;;^UTILITY(U,$J,358.3,7224,1,4,0)
 ;;=4^E10.11
 ;;^UTILITY(U,$J,358.3,7224,2)
 ;;=^5002588
 ;;^UTILITY(U,$J,358.3,7225,0)
 ;;=E10.22^^49^479^18
 ;;^UTILITY(U,$J,358.3,7225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7225,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Chr Kidney Disease
 ;;^UTILITY(U,$J,358.3,7225,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,7225,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,7226,0)
 ;;=E10.29^^49^479^20
 ;;^UTILITY(U,$J,358.3,7226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7226,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Kidney Complication NEC
 ;;^UTILITY(U,$J,358.3,7226,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,7226,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,7227,0)
 ;;=E10.331^^49^479^40
 ;;^UTILITY(U,$J,358.3,7227,1,0)
 ;;=^358.31IA^4^2
